Tarceva May Improve Survival From Lung Cancer

Patients whose advanced lung cancers bear the EGFR mutation survive 2 to 3 times longer if given initial treatment with Tarceva.

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.